We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gel Electrophoresis Imager

By Biotechdaily staff writers
Posted on 14 Sep 2005
A new difference gel electrophoresis (DIGE) imager is a scanning charge coupled device (CCD) camera-based instrument created specifically for generating high-resolution images of the multi-channel two-dimensional (2D) gels produced by DICE experiments.

The Ettan imaging system, developed by GE Healthcare (Waukesha, WI, USA), was designed for highly sensitive imaging of Cy2, Cy3, and Cy5 fluorescent dyes, and provides an easy-to-use system for multi-channel imaging of 2D DIGE gels. More...
It is also compatible with other fluorescently labeled gels in either a single channel or multi-channel modality. The high-resolution images produced can then be analyzed utilizing GE Healthcare's ImageMaster or DeCyder software.

"The Ettan DIGE imager is the first imaging instrument to be designed from the group up to meet the high permanence requirements of 2D DIGE,” commented Robert Marchmont, global marketing director for 2D labeling and detection, GE Healthcare. "Customers who want to take advantage of the benefits of DIGE technology for high-resolution protein separations but do not require the throughput or breadth of applications offered by our Typhoon imaging product will appreciate the combination of high sensitivity and ease of use offered by the Ettan DIGE imager.”





Related Links:
GE Healthcare

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.